No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
Updated: 2026-05-29 · v2.0 · Prof. G. Pkhakadze, MD, MPH, PhDCiteEditorial
📰Read the full Glutathione evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.
1
Safe
Glutathione
L-Glutathione (reduced)
Generally SafeLimitedVitamin-Like
RDA
Typical 250–1,000 mg
Target
High GSH:GSSG ratio
Upper limit
No UL
Products
124
Dosage by population group — reference
🔗 Best with: NAC, Alpha-Lipoic Acid, Vitamin C✅ USP Verified, NSF Contents Certified, ConsumerLab Approved
⚠ Cancer patient self-supplementing GSH — may protect tumor cells from chemotherapy; discuss with oncologist [1]
⚠ Patient choosing oral GSH over NAC — NAC may be more effective for intracellular GSH synthesis [2]
⚠ Acetaminophen overdose — IV NAC (not oral GSH) is the standard of care for GSH repletion [2]
⚠ Elderly with chronic disease + low GSH — combination of NAC + glycine (GlyNAC) is an emerging approach [1]
ℹ️ Not obtained from food. Made by the body and poorly absorbed from food; there is no daily dietary target.
☑ Risk checker
Chronic liver disease (impaired synthesis) [1]
HIV/AIDS (increased oxidative stress and GSH consumption) [1]
Aging (synthetic capacity declines) [1]
Chronic alcoholism (acetaldehyde conjugation depletes GSH) [2]
Acetaminophen overdose (NAPQI conjugation depletes GSH) [2]
Chronic inflammatory conditions (increased oxidative demand) [1]
Poor protein intake (insufficient cysteine, glycine, glutamate) [2]
Select factors
🔬 Lab interpreter
Recommended test
Blood glutathione (reduced GSH and oxidized GSSG)
Reference range / target
High GSH:GSSG ratio (>90:10)
When to test
Research settings; not routine clinical practice [1].
Reflects systemic redox status. Low GSH or low GSH:GSSG ratio indicates oxidative stress [1].
Full lab monitoring ↓
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Glutathione is the master intracellular antioxidant but oral bioavailability is the Achilles heel — standard oral GSH is extensively degraded. NAC (600–1,200 mg/day) is generally more effective at raising intracellular GSH because it provides the rate-limiting cysteine substrate. If supplementing GSH directly, use liposomal or S-acetyl forms. Do NOT supplement during chemotherapy without oncologist guidance [1] [2] [3].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
GSH is naturally present in all cells. No specific oral GSH supplementation data in pregnancy. NAC (Category B) is better studied for raising GSH in pregnancy [2].
👦 Pediatric: See guidance
No established pediatric dose for oral GSH supplementation. Children synthesize GSH normally from dietary amino acids. NAC is used in pediatrics for acetaminophen overdose and as mucolytic [2].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose

How to take

🍽 Timing: Take on empty stomach for best absorption (if using oral GSH) [3].
💊 With food: Empty stomach preferred for oral GSH. NAC also best on empty stomach [2].
🚫 Avoid: Do NOT supplement during chemotherapy without oncologist approval [1]. Standard reduced GSH powder may have very limited bioavailability [3].
2 Which form?
FormBioavailabilityVeganCost
['Reduced L-glutathione (standard)', 'common', 'The active thiol form. Oral bioavailability is limited by GGT degradation in the gut and liver. Some studies show modest plasma GSH increases at 500–1,000 mg/day [3].']StandardCheck label
['Liposomal glutathione', 'preferred', 'Encapsulated in phospholipid vesicles to bypass GI degradation. Higher plasma levels than standard oral GSH. More expensive [3].']StandardCheck label
['S-Acetyl glutathione', '', 'Acetylated form resistant to GGT degradation. Crosses cell membranes and is deacetylated intracellularly. Emerging evidence for better intracellular delivery [3].']StandardCheck label
['IV glutathione', '', 'Bypasses GI tract entirely. Used clinically in Parkinson disease research and in some integrative medicine protocols. Not available OTC [3].']StandardCheck label
['NAC (as precursor)', 'preferred', 'N-Acetylcysteine provides the rate-limiting cysteine for endogenous GSH synthesis. May be more effective than oral GSH for raising intracellular levels [2].']StandardCheck label
3 Common questions
Is oral glutathione effective?
This is the central debate. Standard oral GSH is extensively degraded by GGT in the gut. However, a 2015 RCT showed that 500–1,000 mg/day oral GSH for 6 months modestly increased blood GSH [5]. Liposomal and S-acetyl forms may improve delivery. Many clinicians prefer NAC (600–1,200 mg/day) as it provides the rate-limiting cysteine for cells to synthesize their own GSH [2] [3].
Is NAC better than glutathione supplements?
Arguably yes for raising intracellular GSH, because NAC provides cysteine — the rate-limiting substrate — and cells synthesize GSH where it's needed (intracellularly). Oral GSH must survive GI degradation and cross cell membranes intact [2]. However, liposomal GSH may offer advantages for direct GSH delivery, particularly in individuals with impaired synthetic capacity.
Why does glutathione decline with age?
GSH synthetic capacity decreases with aging due to reduced activity of glutamate-cysteine ligase (the rate-limiting enzyme) and reduced cysteine availability. By age 80, GSH levels may be 50% of young adult levels [1]. This decline is associated with increased oxidative stress and disease susceptibility.
Does glutathione lighten skin?
Some small trials in Southeast Asia showed that oral GSH (500 mg/day) reduced melanin index, leading to lighter skin tone [3]. This is due to GSH's inhibition of tyrosinase. This is NOT a medical indication and raises ethical questions about skin-lightening marketing. The cosmetic industry has promoted this use aggressively in some markets.
4 Clinical evidence

Strong

Glutathione is the master intracellular antioxidant — depletion is associated with oxidative stress in virtually every chronic disease (liver disease, HIV, COPD, diabetes, neurodegeneration) [1]. IV glutathione acutely raises plasma and tissue GSH levels [3]. NAC (as precursor) effectively raises intracellular GSH — this is the basis for its use as the acetaminophen overdose antidote [2]. HIGH

Moderate

Oral glutathione: a randomized trial (n = 54) showed that 250–1,000 mg/day oral GSH for 6 months modestly increased blood GSH levels and reduced oxidative stress markers [5]. Liposomal GSH: small studies show superior plasma elevation compared to standard oral GSH [3]. Skin lightening: oral GSH has been marketed for skin whitening (melanogenesis inhibition), with some small positive trials — this is controversial and not a medical indication [3]. NAFLD: small trials of oral GSH or IV GSH show improved liver markers [3]. MODERATE

Insufficient

Parkinson disease: IV GSH has been studied in pilot trials with mixed results [3]. Cancer adjunct: theoretical (GSH depletion in cancer cells) but clinical data are lacking and GSH could theoretically protect tumor cells too [1]. Anti-aging: theoretical based on age-related GSH decline but no outcome trials [1]. Athletic performance: limited and inconsistent data [3]. Autism: some pilot studies of GSH-related interventions, insufficient for recommendation [3]. LOW
5 Safety, toxicity & adverse events

Relative

⚠ Asthma — inhaled forms may trigger bronchospasm (caution by analogy)
⚠ Sulfur sensitivity
⚠ Pregnancy and lactation — insufficient safety data

🚩 Red flags

Cancer patient supplementing GSH without oncologist knowledge — potential interference with chemotherapy [1]
Patient spending money on standard oral GSH when NAC would be more effective and cheaper [2]
IV glutathione 'drip bar' without medical supervision — unregulated, infection risk, uncertain benefit [3]
6 Interactions

Drug interactions

Chemotherapy agents (general) Major
Mechanism: GSH conjugation is a major detoxification pathway for many chemotherapy drugs. Supplemental GSH may reduce drug efficacy by protecting tumor cells. [1]
Effect: Potential reduced chemotherapy efficacy. [1]
Action: Do NOT supplement GSH during active chemotherapy without oncologist approval [1].

Supplement synergies

NAC · 600–1,200 mg/day NAC
NAC provides cysteine — the rate-limiting substrate for GSH synthesis. NAC + direct GSH covers both synthesis and direct supplementation [2].
Glycine + NAC (GlyNAC) · 1.2 g NAC + 1.2 g glycine BID
GlyNAC provides both rate-limiting substrates (cysteine + glycine). A 2021 RCT in older adults showed GlyNAC reversed GSH deficiency and oxidative stress markers [1].
Vitamin C · 500–1,000 mg/day
Vitamin C recycles oxidized glutathione (GSSG) back to reduced GSH. Synergistic antioxidant cycle [1].
7 Regulatory
United States (FDA): Classified as a dietary supplement. No FDA-approved health claims. IV glutathione is used off-label in integrative medicine [3].
European Union (EFSA): Available as food supplement. No authorized health claims for oral GSH [3].
Japan (MHLW): Glutathione injection is an approved pharmaceutical (Tathione) for liver disorders and chemotherapy-induced toxicity [3].
South Korea / Philippines: Oral and IV GSH widely marketed for skin lightening. Regulatory concern about unregulated IV glutathione 'drip bars' [3].
8 US supplement products
124
on-market products containing Glutathione (NIH DSLD)

Brands carrying Glutathione (56)

Click a brand to see its Glutathione products.
Or browse all 124 products in one list →
9 Frequently paired with
Magnesium 65 sharedZinc 57 sharedVitamin C 57 sharedSelenium 56 sharedVitamin E 52 sharedSilicon 46 shared
Glutathione vs NACGlutathione vs Alpha-Lipoic Acid
10 Cite this page
Vancouver: Pkhakadze G. Glutathione — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 15]. Available from: https://supplement.ge/ingredients/glutathione/
APA 7th: Pkhakadze, G. (2026). Glutathione — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/glutathione/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: February 2027
References: 5 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Glutathione — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/glutathione/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG